(1R)-Trans-Tetramethrin

(1R)-Trans-Tetramethrin

SCHEMBL2973441

CC(C)=C[C@@H]1[C@@H](C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.56
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 4/20 0.38
TRPV1 Q8NER1 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ADRA2A P08913 1/20 0.32
CNR1 P21554 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetramethrin SCHEMBL27009 1.00 LMNA (0.56) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL22714265 1.00 LMNA (0.56) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL7926801 1.00 LMNA (0.56) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL28849516 0.95 LMNA (0.53) LMNACYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL11625926 0.89 LMNA (0.45) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL5883725 0.89 LMNA (0.52) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL4422842 0.88 LMNA (0.46) LMNACYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL13198752 0.88 LMNA (0.47) LMNACYP1A2CYP2C19CYP3A4CYP2D6
Tetramethrin SCHEMBL7176898 0.85 LMNA (0.44) LMNACYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL11775897 0.85 LMNA (0.62) LMNACYP1A2CYP2C19CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 US claimed
EP-4627920-A1 BINARY INSECTICIDE COMPOSITION AND USE THEREOF Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) 2025-10-08 EP claimed
US-20250295123-A1 Arthropod Control Compositions FIRMENICH & CIE (CH) 2025-09-25 US claimed
EP-4426116-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2024-09-11 EP claimed
WO-2024114260-A1 BINARY INSECTICIDE COMPOSITION AND USE THEREOF 沈阳中化农药化工研发有限公司 2024-06-06 WO claimed
CN-118104673-A Synergistic compound composition containing pyrethroid insecticide and application thereof 沈阳中化农药化工研发有限公司 2024-05-31 CN claimed
EP-4326063-A1 IMPROVED BIOCIDE COMPOSITIONS Solugen, Inc. (US) 2024-02-28 EP claimed
US-20230247992-A1 ARTHROPOD CONTROL COMPOSITION FIRMENICH & CIE (CH) 2023-08-10 US claimed
WO-2023117960-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2023-06-29 WO claimed
EP-4181681-A1 ARTHROPOD CONTROL COMPOSITION Firmenich SA (CH) 2023-05-24 EP claimed
EP-1566996-B1 METHOD OF PROTECTING SEEDS TREATED WITH A PHYTOTOXIC AGENT MONSANTO TECHNOLOGY LLC (US) 2009-11-11 EP claimed
CN-1719970-A Method of protecting seeds treated with a phytotoxic agent MONSANTO TECHNOLOGY LLC (US) 2006-01-11 CN claimed
WO-2004049778-A9 METHOD OF PROTECTING SEEDS TREATED WITH A PHYTOTOXIC AGENT MONSANTO TECHNOLOGY LLC (US) 2005-09-22 WO claimed
US-20050197251-A1 Method of controlling the release of agricultural active ingredients from treated plant seeds MONSANTO TECHNOLOGY, L.L.C. (US) 2005-09-08 US claimed
EP-1566996-A1 METHOD OF PROTECTING SEEDS TREATED WITH A PHYTOTOXIC AGENT Monsanto Technology LLC (US) 2005-08-31 EP claimed
US-20040259732-A1 Treatment of plants and plant propagation materials with an antioxidant to improve plant health and/or yield MONSANTO TECHNOLOGY, L.L.C. 2004-12-23 US claimed
WO-2004095926-A2 TREATMENT OF PLANTS AND PLANT PROPAGATION MATERIALS WITH AN ANTIOXIDANT TO IMPROVE PLANT HEALTH AND/OR YIELD MONSANTO TECHNOLOGY, LLC (US) 2004-11-11 WO claimed
US-20040118040-A1 Method of protecting seeds treated with a phytotoxic agent MONSANTO TECHNOLOGY, L.L.C. 2004-06-24 US claimed
WO-2004049778-A1 METHOD OF PROTECTING SEEDS TREATED WITH A PHYTOTOXIC AGENT MONSANTO TECHNOLOGY, LLC (US) 2004-06-17 WO claimed
US-20020134012-A1 Method of controlling the release of agricultural active ingredients from treated plant seeds MONSANTO TECHNOLOGY, L.L.C. 2002-09-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 LMNA 2249/4885CYP1A2 841/4885CYP2C19 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.